Better Therapeutics, Inc.
At Close: 4:00 PM
BTTX Stock Price Graph
BTTX Stock Price Today
Better Therapeutics, Inc. (BTTX) stock rallied over 8.95% intraday to trade at $0.207 a share on NASDAQ. The stock opened with a gain of 5.26% at $0.20 and touched an intraday high of $0.20, rising 8.95% against the last close of $0.19. The Better Therapeutics, Inc. in stock market went to a low of $0.18 during the session.
BTTX Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
BTTX Stock Price History Chart
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
Frequently Asked Questions
What is the current Better Therapeutics, Inc. (BTTX) stock price?
Better Therapeutics, Inc. (NASDAQ: BTTX) stock price is $0.21 in the last trading session. During the trading session, BTTX stock reached the peak price of $0.20 while $0.18 was the lowest point it dropped to. The percentage change in BTTX stock occurred in the recent session was 8.95% while the dollar amount for the price change in BTTX stock was $0.02.
BTTX's industry and sector of operation?
The NASDAQ listed BTTX is part of Biotechnology industry that operates in the broader Healthcare sector. Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States.
Who are the executives of BTTX?
Mr. Kevin J. Appelbaum
Co-Founder & Director
Mr. Frank L. Karbe
Chief Executive Officer, Pres & Director
Mr. Mark Heinen
Head of Fin. & Interim Chief Financial Officer
Mr. Andres Camacho
Senior Vice President of Technology & Head of Engineering
How BTTX did perform over past 52-week?
BTTX's closing price is 0.66% higher than its 52-week low of $0.173 where as its distance from 52-week high of $1.67 is -0.70%.
How many employees does BTTX have?
Number of BTTX employees currently stands at N/A. BTTX operates from 548 Market Street, San Francisco, CA 94104, US.
Link for BTTX official website?
Official Website of BTTX is: https://www.bettertx.com
How do I contact BTTX?
How many shares of BTTX are traded daily?
BTTX stock volume for the day was 3134495.00 shares. The average number of BTTX shares traded daily for last 3 months was 1.82 Million.
What is the market cap of BTTX currently?
The market value of BTTX currently stands at $9.81 Million with its latest stock price at $0.21 and N/A of its shares outstanding.